Abstract:The mitochondrial citrate transport protein (CTP), encoded by SLC25A1, accommodates bidirectional trafficking of citrate between the mitochondria and cytosol, supporting lipid biosynthesis and redox homeostasis. Genetic CTP deficiency causes a fatal neurodevelopmental syndrome associated with the accumulation of L- and D-2-hydroxyglutaric acid, and elevated CTP expression is associated with poor prognosis in several types of cancer, emphasizing the importance of this transporter in multiple human pathologies. Here we describe the metabolic consequences of CTP deficiency in cancer cells. As expected from the phenotype of CTP-deficient humans, somatic CTP loss in cancer cells induces broad dysregulation of mitochondrial metabolism, resulting in accumulation of lactate and of the L- and D- enantiomers of 2-hydroxyglutarate (2HG) and depletion of TCA cycle intermediates. It also eliminates mitochondrial import of citrate from the cytosol. To quantify the impact of CTP deficiency on metabolic flux, cells were cultured with a set of 13C-glucose and 13C-glutamine tracers with resulting data integrated by metabolic flux analysis (MFA). CTP-deficient cells displayed a major restructuring of central carbon metabolism, including suppression of pyruvate dehydrogenase (PDH) and induction of glucose-dependent anaplerosis through pyruvate carboxylase (PC). We also observed an unusual lipogenic pathway in which carbon from glucose supplies mitochondrial production of alpha-ketoglutarate (AKG), which is then trafficked to the cytosol and used to supply reductive carboxylation by isocitrate dehydrogenase 1 (IDH1). The resulting citrate is cleaved to produce lipogenic acetyl-CoA, thereby completing a novel pathway of glucose-dependent reductive carboxylation. In CTP deficient cells, IDH1 inhibition suppresses lipogenesis from either glucose or glutamine, implicating IDH1 as a required component of fatty acid synthesis in states of CTP deficiency.

SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism

Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway.

Genomic Organization, Expression, and Subcellular Localization of Mouse Mitochondrial Seryl-Trna Synthetase.

Serine and one-carbon metabolism in cancer

Phenotypic profiling of solute carriers characterizes serine transport in cancer

Serine catabolism is essential to maintain mitochondrial respiration in mammalian cells

Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer

MCART1/SLC25A51 is required for mitochondrial NAD transport

SLC25A51 is a mammalian mitochondrial NAD+ transporter

Tracing the Diverse Paths of One-Carbon Metabolism in Cancer and Beyond

SLC7A11/xCT in Cancer: Biological Functions and Therapeutic Implications.

Decoding Serine Metabolism: Unveiling Novel Pathways for Evolving Cancer Therapies

SLC25A19 is required for NADH homeostasis and mitochondrial respiration

SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells

SLC25A48 controls mitochondrial choline import and metabolism

Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells

Glioma cells require one-carbon metabolism to survive glutamine starvation

SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism

Quantitative Metabolic Flux Analysis Reveals an Unconventional Pathway of Fatty Acid Synthesis in Cancer Cells Deficient for the Mitochondrial Citrate Transport Protein.

SLC7A5 is required for citrulline-dependent growth in arginine limited conditions

The mitochondrial transporter family (SLC25): physiological and pathological implications